• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Ohr Pharmaceutical - Articles and news items


Ohr Pharmaceutical presents data from OHR-102 Phase II study in wet-AMD

Industry news / 7 May 2015 / Victoria White

Ohr Pharmaceutical presented the results from the Phase II IMPACT study evaluating OHR-102 combination therapy for the treatment of the wet-AMD at ARVO…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +